MaRS Innovation Announces Collaboration with Johnson & Johnson Innovation to Advance Early-Stage Technologies Related to Human Health

MaRS Innovation Announces Collaboration with Johnson & Johnson Innovation to Advance Early-Stage Technologies Related to Human Health


TORONTO, Nov. 25, 2013 /PRNewswire/ - MaRS Innovation (MI), a Centre of Excellence for Commercialization and Research, today announced a new collaboration with Johnson & Johnson Innovation and its affiliate Janssen, Inc., in Canada to advance early-stage
technologies related to human health in therapeutics, medical devices,
and diagnostics.


http://photos.prnewswire.com/prnh/20131125/TO802


Through the collaboration, MaRS Innovation and technical experts from
the Johnson & Johnson Innovation Center in Boston, Massachusetts will
jointly identify and fund high-potential opportunities emerging from
well-validated scientific research discoveries within MaRS Innovation's
16 member institutions, which include the University of Toronto and its affiliated teaching hospitals.



"We are looking forward to working with Johnson & Johnson Innovation,"
said Dr. Raphael Hofstein, president and CEO, MaRS Innovation. "There
are many high quality opportunities coming out of the Toronto research
community, and these opportunities can benefit from our close
collaboration."



Through the agreement, Johnson & Johnson Innovation will provide funding
over a three-year period to support promising individual projects based
on joint due diligence, which will be leveraged with financial support
from MaRS Innovation.



The fund will accelerate the development and validation of healthcare
technologies within one of Canada's highly innovative academic
clusters.


About MaRS Innovation
MaRS Innovation is the commercialization agent for Ontario's exceptional discovery
pipeline from 16 leading academic institutions. As a single-entry point to member-based activity of $1 billion in
annual research and development, MI is a gateway for investors and
licensees to access technology assets. Supported by the Government of
Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions, MI is a transformational
partnership that turns research strengths into commercial
opportunities. MI's portfolio includes the most promising assets from its members' pipeline, which it
advances into global markets through industry partnerships, licensing
and company creation.


SOURCE MaRS Innovation

Photo:http://photos.prnewswire.com/prnh/20131125/TO802
http://photoarchive.ap.org/
MaRS Innovation

CONTACT: Media Contact:
Elizabeth Monier-Williams
Marketing and Communications Manager
emonierwilliams@marsinnovation.com
647-260-7850 / @marsinnovation / @wavecheckyellow


-------
Profile: intent